Cross-docking and molecular dynamic studies to achieve the potent antiviral HIV-1 nonnucleoside reverse transcriptase inhibitors. (2023). Science Essence Journal, 39(2), 23-37. https://ejournals.swu.ac.th/sej/article/view/15577